Fulcrum Therapeutics Inc (FULC)
3.32
-0.24
(-6.74%)
USD |
NASDAQ |
Nov 14, 16:00
3.315
0.00 (0.00%)
After-Hours: 20:00
Fulcrum Therapeutics Research and Development Expense (Quarterly): 17.26M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 17.26M |
| March 31, 2024 | 19.77M |
| December 31, 2023 | 19.00M |
| September 30, 2023 | 18.24M |
| June 30, 2023 | 17.85M |
| March 31, 2023 | 16.72M |
| December 31, 2022 | 18.57M |
| September 30, 2022 | 15.37M |
| June 30, 2022 | 25.02M |
| March 31, 2022 | 17.83M |
| December 31, 2021 | 18.91M |
| September 30, 2021 | 17.08M |
| June 30, 2021 | 17.38M |
| Date | Value |
|---|---|
| March 31, 2021 | 16.33M |
| December 31, 2020 | 16.14M |
| September 30, 2020 | 15.64M |
| June 30, 2020 | 12.78M |
| March 31, 2020 | 14.48M |
| December 31, 2019 | 12.09M |
| September 30, 2019 | 13.50M |
| June 30, 2019 | 10.86M |
| March 31, 2019 | 34.63M |
| December 31, 2018 | 6.86M |
| September 30, 2018 | 6.963M |
| June 30, 2018 | 5.788M |
| March 31, 2018 | 5.573M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
12.09M
Minimum
Dec 2019
25.02M
Maximum
Jun 2022
17.18M
Average
17.26M
Median
Jun 2024
Research and Development Expense (Quarterly) Benchmarks
| Bioventus Inc | 3.808M |
| Arcturus Therapeutics Holdings Inc | 39.13M |
| Johnson & Johnson | 4.952B |
| Entrada Therapeutics Inc | 31.26M |
| Tenon Medical Inc | 0.708M |